– New Drug Application follows submission of Marketing Authorisation Application to the European Medicines Agency INDIANAPOLIS and INGELHEIM, Germany, Dec. 20, 2013 / PRNewswire / Asianet-Pakistan – Eli Lilly and Company and Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has accepted the filing of the New Drug Application (NDA) for LY2963016, an […]